USS Co., Ltd. (TYO:4732)

Kronos Bio Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	80,087	113,219	109,009	92,692	79,380	67,770
Short-Term Investments	11,500	3,000	3,000	3,000	3,000	3,000
Cash & Short-Term Investments	91,587	116,219	112,009	95,692	82,380	70,770
Cash Growth	-13.27%	3.76%	17.05%	16.16%	16.41%	24.75%
Receivables	25,995	24,777	27,105	16,261	16,979	8,788
Inventory	1,497	1,656	1,651	1,843	1,206	1,028
Prepaid Expenses	-	220	182	163	167	161
Other Current Assets	2,932	1,769	7,424	2,098	3,140	781
Total Current Assets	122,011	144,641	148,371	116,057	103,872	81,528
Property, Plant & Equipment	98,744	98,333	98,996	100,604	100,379	103,302
Long-Term Investments	12,023	6,585	7,067	8,562	7,197	6,565
Goodwill	6,612	6,747	7,287	7,826	8,366	8,906
Other Intangible Assets	6,148	6,119	5,499	5,719	6,209	6,282
Long-Term Deferred Tax Assets	-	4,885	4,312	3,553	3,299	4,071
Other Long-Term Assets	-477	2	2	2	2	1
Total Assets	245,061	267,348	271,557	242,352	229,354	210,699
Accounts Payable	806	30,909	44,740	23,450	21,911	12,495
Accrued Expenses	-	1,071	1,010	889	782	767
Short-Term Debt	530	340	150	340	186	-
Current Portion of Long-Term Debt	517	220	220	220	220	220
Current Portion of Leases	-	34	55	34	36	7
Current Income Taxes Payable	4,934	10,215	9,128	7,864	7,578	7,408
Other Current Liabilities	38,982	8,362	7,827	6,476	7,171	6,025
Total Current Liabilities	45,769	51,151	63,130	39,273	37,884	26,922
Long-Term Debt	1,327	1,617	2,215	1,794	2,356	2,911
Long-Term Leases	-	34	24	31	28	35
Long-Term Deferred Tax Liabilities	-	8	-	-	-	747
Other Long-Term Liabilities	6,121	6,177	6,193	6,174	5,740	5,784
Total Liabilities	54,251	59,994	72,536	48,199	46,880	37,175
Common Stock	18,881	18,881	18,881	18,881	18,881	18,881
Additional Paid-In Capital	9,038	9,057	8,992	8,992	18,915	18,911
Retained Earnings	175,339	214,166	196,225	180,137	211,843	196,315
Treasury Stock	-10,518	-32,958	-23,298	-12,034	-65,039	-57,435
Comprehensive Income & Other	-4,929	-4,942	-4,800	-4,522	-4,262	-4,845
Total Common Equity	187,811	204,204	196,000	191,454	180,338	171,827
Minority Interest	2,999	3,150	3,021	2,699	2,136	1,697
Shareholders' Equity	190,810	207,354	199,021	194,153	182,474	173,524
Total Liabilities & Equity	245,061	267,348	271,557	242,352	229,354	210,699
Total Debt	2,374	2,245	2,664	2,419	2,826	3,173
Net Cash (Debt)	89,213	113,974	109,345	93,273	79,554	67,597
Net Cash Growth	-13.44%	4.23%	17.23%	17.24%	17.69%	25.95%
Net Cash Per Share	187.04	237.78	226.30	190.35	159.92	135.32
Filing Date Shares Outstanding	463.1	473.31	480.37	489.17	488.85	498.61
Total Common Shares Outstanding	463.1	473.31	446.75	489.17	490.4	498.61
Working Capital	76,242	93,490	85,241	76,784	65,988	54,606
Book Value Per Share	405.55	431.44	438.73	391.38	367.74	344.61
Tangible Book Value	175,051	191,338	183,214	177,909	165,763	156,639
Tangible Book Value Per Share	378.00	404.26	410.11	363.69	338.02	314.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.